Target intelligence / Profile preview

Dendritic cell pattern-recognition receptors (DC PRRs) (DC PRRs)

Target
DC PRRs
Molecular classification
Receptor, Toll-like receptor family, C-type lectin receptor family, NOD-like receptor family, RIG-I-like receptor family
01

Overview

Dendritic cell pattern-recognition receptors (PRRs) are a diverse group of germline-encoded proteins expressed by dendritic cells to detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Wikipedia, 2024; NIH, 2024). These receptors, which include Toll-like receptors (TLRs), C-type lectin receptors (CLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), serve as the primary sensors of the innate immune system (NIH, 2024; British Society for Immunology, 2024). Upon activation, they trigger signaling cascades that lead to dendritic cell maturation, cytokine production, and the initiation of adaptive immune responses by presenting antigens to T cells (NIH, 2023; British Society for Immunology, 2024). In therapeutic contexts, PRR agonists such as imiquimod and CpG oligonucleotides are used as vaccine adjuvants and cancer immunotherapies to enhance immune surveillance (Wikipedia, 2024; MDPI, 2023). Targeting specific PRRs on dendritic cell subsets allows for precise modulation of the immune system, though challenges such as systemic toxicity (e.g., cytokine release syndrome) and the risk of inducing autoimmunity remain significant concerns (NIH, 2024; MDPI, 2023).

Other names
Pattern recognition receptorsInnate immune receptorsDC surface receptorsDendritic cell innate receptors
02

Mechanism of action

Agonism of innate immune receptors to stimulate dendritic cell maturation and antigen presentation; antagonism to inhibit pathological inflammatory signaling; targeted delivery of antigens via receptor-mediated endocytosis.

03

Biological functions

Immune responseSignal transductionAntigen presentationCytokine productionCell maturationImmune tolerance
04

Disease associations

CancerInfectionInflammationAutoimmune diseaseAllergy
05

Safety considerations

Cytokine release syndromeSystemic inflammationAutoimmunityInjection site reactionsOff-target immune activation
06

Interacting drugs

Imiquimod

7 more in the full profile.

07

Biomarkers

CD80CD83CD86HLA-DRInterferon-alphaInterleukin-12TNF-alpha

Beyond the preview

Go deeper on Dendritic cell pattern-recognition receptors (DC PRRs) (DC PRRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic cell pattern-recognition receptors (DC PRRs) (DC PRRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call